Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiangyi Zheng
Observed name:
Zheng, Xiangyi
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Shanghai Public Health Clinical Center,
Zhongnan Hospital of Wuhan University,
Huashan Hospital
Observed institutions:
Shanghai Medical College of Fudan University,
Harbin Medical University,
Shenzhen University,
Fudan University,
Shanghai Public Health Clinical Center,
Zhongnan Hospital of Wuhan University,
Shenzhen University Health Science Center,
Huashan Hospital
show all 8
ORCID:
0009-0000-3051-8896
Observed ORCID:
0009-0000-3051-8896
OpenAlex ID:
A5040609314
LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations
2017
·
Yongsheng Li
, Lili Li
, et al.
·
Nucleic Acids Research
·
157
PDF
Complex impact of DNA methylation on transcriptional dysregulation across 22 human cancer types
2020
·
Zishan Wang
, Jiaqi Yin
, et al.
·
Nucleic Acids Research
·
34
PDF
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer
2023
·
Yongheng Chen
, Ying Ying
, et al.
·
Cell Death and Disease
·
30
PDF
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
·
Cancer Research
·
20
Targeting Ferroptosis as an Advance Strategy in Cancer Therapy
2024
·
Tobias Achu Muluh
, Qianqian Fu
, et al.
·
Antioxidants and Redox Signaling
·
16
HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development
2025
·
Lu Chen
, Wenxuan Li
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
9
Compound Kushen Injection suppresses multiple myeloma progression via TOP1-targeted coordination of DNA damage and endoplasmic reticulum stress
2025
·
Guopeng Chen
, Ruihang Li
, et al.
·
Phytomedicine
·
1
Data from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
·
1
Supplementary Figure 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
PDF
Supplementary Figure 7 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Figure 5 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Figure 8 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Figure 4 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
PDF
Data from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Figure 8 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
PDF
Supplementary Materials and Methods from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
PDF
Supplementary Table 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Table 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Table 3 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Table 4 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Figure 7 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
PDF
Supplementary Figure 2 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Figure 6 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
Supplementary Figure 1 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
PDF
Supplementary Figure 6 from Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer–Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression
2024
·
Yongheng Chen
, Ying Ying
, et al.
PDF
Show more works
View as search
Works count:
54
Citation count:
268
H-index:
6
I10-index:
5
Year
Topic
Type